Drug Shortage Report for ARZERRA

Last updated on 2018-10-17 History
Report ID 4096
Drug Identification Number 02381559
Brand name ARZERRA
Common or Proper name ARZERRA 100MG VIALS
Company Name NOVARTIS PHARMACEUTICALS CANADA INC
Active Ingredient(s) Ofatumumab
Strength(s) 100MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 5ML X 3
ATC code L01XC
ATC description OTHER ANTINEOPLASTIC AGENTS
Reason for shortage Other (Please describe in comments)
Anticipated start date 2017-08-01
Actual start date 2017-09-21
Estimated end date
Actual end date 2018-09-26
Shortage status Resolved
Updated date 2018-10-17
Company comments Being assessed for discontinuation - communication to follow
Health Canada comments
Contact Address 385 BOUCHARD BLVD
DORVAL, QUEBEC
CANADA H9S 1A9
Company contact information customer.relations@novartis.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v17 2018-10-17 French Compare
v16 2018-10-17 English Compare
v15 2018-10-17 English Compare
v14 2018-10-17 English Compare
v13 2018-10-17 English Compare
v12 2018-09-27 English Compare
v11 2018-09-26 French Compare
v10 2018-09-26 English Compare
v9 2018-09-26 French Compare
v8 2018-09-26 English Compare
v7 2018-09-26 English Compare
v6 2017-11-30 French Compare
v5 2017-11-30 English Compare
v4 2017-08-02 English Compare
v3 2017-03-23 French Compare
v2 2017-03-23 English Compare
v1 2017-03-23 English Compare